Tianshui Zhongxing Bio-technology Co.,Ltd.
Symbole: 002772.SZ
SHZ
7.08
CNYPrix du marché aujourd'hui
-764.5012
Ratio P/E
44.3411
Ratio PEG
2.78B
Cap MRK
- 0.00%
Rendement DIV
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1323.5 | 1695.7 | 1858.6 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 285 | 369.5 | 263.4 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 28.3 | 80.9 | 21.6 | |||||||||||||
balance-sheet.row.inventory | 0 | 1274.6 | 1255.5 | 1173.9 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.8 | 4.8 | 24.4 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 2659.2 | 3036.9 | 3078.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2946.8 | 3074 | 3005.4 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 123.7 | -285.2 | -170.9 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 268.3 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 9.7 | 401.1 | 19.3 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3414.6 | 3532.3 | 3472.8 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.account-payables | 0 | 179.1 | 205.4 | 155.6 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 1009.7 | 980.4 | 422.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 1 | 1 | 0.7 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1074.5 | 1622.5 | 2330.7 | |||||||||||||
Deferred Revenue Non Current | 0 | 102.9 | 118.5 | 127.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 266.7 | 252.2 | 234.8 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1074.7 | 1741 | 2480.6 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0.3 | |||||||||||||
balance-sheet.row.total-liab | 0 | 2535.3 | 3184.5 | 3300.2 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0 | 393.2 | 407.5 | 407.4 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | 958.9 | 931.5 | 819.4 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 60 | 26.1 | 27.3 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2020.3 | 2016.6 | 1994.5 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3432.5 | 3381.6 | 3248.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 3 | 3.1 | 2.5 | |||||||||||||
balance-sheet.row.total-equity | 0 | 3435.5 | 3384.7 | 3251.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 408.7 | 84.3 | 92.5 | |||||||||||||
balance-sheet.row.total-debt | 0 | 2084.4 | 2602.9 | 2753.3 | |||||||||||||
balance-sheet.row.net-debt | 0 | 1045.9 | 1276.7 | 1158.1 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 159.6 | 158.9 | 54.3 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10.9 | -28 | |||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 10.9 | 28 | |||||||||||||
cash-flows.row.change-in-working-capital | 0 | -11.7 | -77.9 | -788.6 | |||||||||||||
cash-flows.row.account-receivables | 0 | 20.7 | -35.7 | 2.5 | |||||||||||||
cash-flows.row.inventory | 0 | -26.3 | -85.4 | -912.1 | |||||||||||||
cash-flows.row.account-payables | 0 | -6.1 | 43.2 | 121 | |||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-non-cash-items | 0 | 107.8 | 137.3 | 63.1 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 3 | 0.4 | |||||||||||||
cash-flows.row.purchases-of-investments | 0 | -400 | -1310 | -510 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 450 | 1172.5 | 959.4 | |||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.7 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -57 | -380.4 | 164.1 | |||||||||||||
cash-flows.row.debt-repayment | 0 | -544.4 | -1520.6 | -680.8 | |||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | -117.9 | -170.3 | -148.7 | |||||||||||||
cash-flows.row.other-financing-activites | 0 | -92.9 | 1323 | 1459.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -755.2 | -367.9 | 630.1 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.net-change-in-cash | 0 | -287.7 | -254.6 | 380.6 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1038.5 | 1326.2 | 1580.8 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1326.2 | 1580.8 | 1200.2 | |||||||||||||
cash-flows.row.operating-cash-flow | 0 | 524.5 | 493.7 | -413.7 | |||||||||||||
cash-flows.row.capital-expenditure | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.free-cash-flow | 0 | 417.5 | 247.8 | -700.2 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1928.1 | 1970.3 | 1556.1 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1500.6 | 1468.8 | 1268.2 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 427.5 | 501.5 | 288 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 247.2 | 231 | 187.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1747.7 | 1699.8 | 1455.6 | |||||||||||||
income-statement-row.row.interest-income | 0 | 31.6 | 31 | 53.6 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 180.4 | 307.6 | 121.6 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 162.8 | 158.9 | 54.3 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 0 | 66.7 | |||||||||||||
income-statement-row.row.net-income | 0 | 159.6 | 158.4 | -12.4 |
Questions fréquemment posées
Quel est le total de Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) de l'actif total?
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) Le total des actifs est 6073765300.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.149.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.517.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.002.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.001.
Qu'est-ce que Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 159581340.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 2084417918.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 247154405.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.